183 related articles for article (PubMed ID: 34214079)
1. eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants.
Thornton AM; Fang L; Lo A; McSharry M; Haan D; O'Brien C; Berger AH; Giannakis M; Brooks AN
PLoS Comput Biol; 2021 Jul; 17(7):e1009132. PubMed ID: 34214079
[TBL] [Abstract][Full Text] [Related]
2. An expression-based variant impact phenotyping protocol to predict the impact of gene variants in cell lines.
Thornton AM; Tumu M; Brooks AN
STAR Protoc; 2022 Sep; 3(3):101651. PubMed ID: 36092819
[TBL] [Abstract][Full Text] [Related]
3. The Functional Landscape of Patient-Derived RNF43 Mutations Predicts Sensitivity to Wnt Inhibition.
Yu J; Yusoff PAM; Woutersen DTJ; Goh P; Harmston N; Smits R; Epstein DM; Virshup DM; Madan B
Cancer Res; 2020 Dec; 80(24):5619-5632. PubMed ID: 33067269
[TBL] [Abstract][Full Text] [Related]
4. RNF43 G659fs is an oncogenic colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition.
Fang L; Ford-Roshon D; Russo M; O'Brien C; Xiong X; Gurjao C; Grandclaudon M; Raghavan S; Corsello SM; Carr SA; Udeshi ND; Berstler J; Sicinska E; Ng K; Giannakis M
Nat Commun; 2022 Jun; 13(1):3181. PubMed ID: 35676246
[TBL] [Abstract][Full Text] [Related]
5. Commonly observed RNF43 mutations retain functionality in attenuating Wnt/β-catenin signaling and unlikely confer Wnt-dependency onto colorectal cancers.
Li S; Lavrijsen M; Bakker A; Magierowski M; Magierowska K; Liu P; Wang W; Peppelenbosch MP; Smits R
Oncogene; 2020 Apr; 39(17):3458-3472. PubMed ID: 32103169
[TBL] [Abstract][Full Text] [Related]
6. RNF43 R117fs mutant positively regulates Wnt/β-catenin signaling by failing to internalize FZD expressed on the cell surface.
Cho AR; Sul HJ; Kim YJ; Kim B; Zang DY
Sci Rep; 2022 Apr; 12(1):7013. PubMed ID: 35487932
[TBL] [Abstract][Full Text] [Related]
7. Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer.
Yamamoto D; Oshima H; Wang D; Takeda H; Kita K; Lei X; Nakayama M; Murakami K; Ohama T; Takemura H; Toyota M; Suzuki H; Inaki N; Oshima M
J Pathol; 2022 May; 257(1):39-52. PubMed ID: 35040131
[TBL] [Abstract][Full Text] [Related]
8. RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis.
Bond CE; McKeone DM; Kalimutho M; Bettington ML; Pearson SA; Dumenil TD; Wockner LF; Burge M; Leggett BA; Whitehall VL
Oncotarget; 2016 Oct; 7(43):70589-70600. PubMed ID: 27661107
[TBL] [Abstract][Full Text] [Related]
9. The most common RNF43 mutant G659Vfs*41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis.
Tu J; Park S; Yu W; Zhang S; Wu L; Carmon K; Liu QJ
Sci Rep; 2019 Dec; 9(1):18557. PubMed ID: 31811196
[TBL] [Abstract][Full Text] [Related]
10. Impact of loss-of-function mutations at the RNF43 locus on colorectal cancer development and progression.
Eto T; Miyake K; Nosho K; Ohmuraya M; Imamura Y; Arima K; Kanno S; Fu L; Kiyozumi Y; Izumi D; Sugihara H; Hiyoshi Y; Miyamoto Y; Sawayama H; Iwatsuki M; Baba Y; Yoshida N; Furukawa T; Araki K; Baba H; Ishimoto T
J Pathol; 2018 Aug; 245(4):445-455. PubMed ID: 29756208
[TBL] [Abstract][Full Text] [Related]
11. RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF
Elez E; Ros J; Fernández J; Villacampa G; Moreno-Cárdenas AB; Arenillas C; Bernatowicz K; Comas R; Li S; Kodack DP; Fasani R; Garcia A; Gonzalo-Ruiz J; Piris-Gimenez A; Nuciforo P; Kerr G; Intini R; Montagna A; Germani MM; Randon G; Vivancos A; Smits R; Graus D; Perez-Lopez R; Cremolini C; Lonardi S; Pietrantonio F; Dienstmann R; Tabernero J; Toledo RA
Nat Med; 2022 Oct; 28(10):2162-2170. PubMed ID: 36097219
[TBL] [Abstract][Full Text] [Related]
12. Loss of endogenous RNF43 function enhances proliferation and tumour growth of intestinal and gastric cells.
Neumeyer V; Grandl M; Dietl A; Brutau-Abia A; Allgäuer M; Kalali B; Zhang Y; Pan KF; Steiger K; Vieth M; Anton M; Mejías-Luque R; Gerhard M
Carcinogenesis; 2019 Jun; 40(4):551-559. PubMed ID: 30380024
[TBL] [Abstract][Full Text] [Related]
13. RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.
Fennell LJ; Clendenning M; McKeone DM; Jamieson SH; Balachandran S; Borowsky J; Liu J; Kawamata F; Bond CE; Rosty C; Burge ME; Buchanan DD; Leggett BA; Whitehall VLJ
Fam Cancer; 2018 Jan; 17(1):63-69. PubMed ID: 28573495
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer.
Seeber A; Battaglin F; Zimmer K; Kocher F; Baca Y; Xiu J; Spizzo G; Novotny-Diermayr V; Rieder D; Puccini A; Swensen J; Ellis M; Goldberg RM; Grothey A; Shields AF; Marshall JL; Weinberg BA; Sackstein PE; Lim KH; Tan GS; Nabhan C; Korn WM; Amann A; Trajanoski Z; Berger MD; Lou E; Wolf D; Lenz HJ
Clin Cancer Res; 2022 May; 28(9):1863-1870. PubMed ID: 35254413
[TBL] [Abstract][Full Text] [Related]
15. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY
Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244
[TBL] [Abstract][Full Text] [Related]
16. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma.
Jiang X; Hao HX; Growney JD; Woolfenden S; Bottiglio C; Ng N; Lu B; Hsieh MH; Bagdasarian L; Meyer R; Smith TR; Avello M; Charlat O; Xie Y; Porter JA; Pan S; Liu J; McLaughlin ME; Cong F
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12649-54. PubMed ID: 23847203
[TBL] [Abstract][Full Text] [Related]
17. Next-generation sequencing reveals heterogeneous genetic alterations in key signaling pathways of mismatch repair deficient colorectal carcinomas.
Wang J; Li R; He Y; Yi Y; Wu H; Liang Z
Mod Pathol; 2020 Dec; 33(12):2591-2601. PubMed ID: 32620917
[TBL] [Abstract][Full Text] [Related]
18. RNF43 mutation analysis in serrated polyposis, sporadic serrated polyps and Lynch syndrome polyps.
van Herwaarden YJ; Koggel LM; Simmer F; Vink-Börger EM; Dura P; Meijer GA; Nagengast FM; Hoogerbrugge N; Bisseling TM; Nagtegaal ID
Histopathology; 2021 Apr; 78(5):749-758. PubMed ID: 33098683
[TBL] [Abstract][Full Text] [Related]
19. Ring Finger 43 Hot-spot Frameshift Mutation G659V in Colorectal Cancer Patients: Report from a Tertiary Cancer Care Hospital in North India.
Vasudevan S; Mehta A; Karki D; Kumar D
Int J Appl Basic Med Res; 2024; 14(1):17-22. PubMed ID: 38504846
[TBL] [Abstract][Full Text] [Related]
20. Protease associated domain of RNF43 is not necessary for the suppression of Wnt/β-catenin signaling in human cells.
Radaszkiewicz T; Bryja V
Cell Commun Signal; 2020 Jun; 18(1):91. PubMed ID: 32527265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
